In other disease areas, mAbs have been shown to deliver improvements in specificity (and potency), safety profile, and dosing frequency (4-week serum half-life), and whilst clinical development times can be shorter than small molecules, mAbs are also large, complex and more costly to manufacture at scale, especially where newer mAb formats prove to be the candidate molecule of choice
For readers comparing branding styles, remember that lowercase and title case can sometimes refer to different discussions or contexts, such as marketing copy or user-to-user shorthand
If you choose to resume B12/MIC supplementation after the 3-month washout period, you can repeat the same protocol again
Particles that should never enter the bloodstream begin to slip through, triggering immune responses and systemic inflammation
It should slide gently toward the powder at the bottom